Plus   Neg

Acura Pharma Q4 Loss Narrows - Quick Facts

Acura Pharmaceuticals, Inc. (ACUR) reported a net loss applicable to common stockholders for the fourth-quarter of $1.62 million or $0.03 per share, narrower than $2.9 million or $0.06 per share in the year-ago quarter.

The company did not generate any revenue in the latest quarter, compared to $359, 000 generated in the prior year quarter.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Follow RTT